Working Note: Sammaan Capital

Knowledge Snapshot

This file is internal issuer coverage memory. It records objective context so that a new research agent with zero prior knowledge can continue coverage without repeating already confirmed checks. Detailed figures are stored in data/sammaan_capital_key_metrics_20260521.json; this file keeps only the credit-relevant context and trends.

Last updated: 2026-06-12

Issuer Overview

• Sammaan Capital Limited is the former Indiabulls Housing Finance Limited and uses the debt ticker IHFLIN.
• It is an Indian non-bank financial company / housing finance-oriented lender with core businesses in housing loans, loans against property, secured business finance, and commercial real estate-related lending.
• Company materials describe Sammaan Capital as an Upper Layer NBFC designated by the RBI, so the credit analysis should focus on loan asset quality, capital, liquidity, market funding, co-lending / direct assignment, regulatory capital, and sponsor support rather than a deposit franchise.

Core Credit View

• Sammaan Capital should be treated as a sponsor-supported reconstruction NBFC after a legacy loan-book clean-up, not as a fully seasoned high-quality NBFC.
• The March 31, 2026 IHC / Avenir promoter transaction materially improved the support story through capital injection, expected governance involvement, and rating-agency recognition.
• Expected IHC support is a major credit factor, but no explicit guarantee, keepwell, or debt payment obligation from IHC / Avenir has been confirmed.
• FY2026 results included a very large loss and reduced equity, so the credit profile still depends on FY2027 evidence of normal profitability, asset-quality stability, and funding access.

Business and Franchise View

• The company-defined end-FY2026 restart AUM was Rs 53,160 crore, split mainly among housing finance, secured business loans / LAP, commercial real estate and project-related exposure, and a small other-loans bucket.
• Housing finance is the most defensive part of the book, while commercial real estate and project-related exposure remain important risk areas because they overlap with the legacy stress history.
• The company targets a much larger product and branch footprint by FY2029. That plan can support franchise recovery but also increases underwriting, systems, collections, staffing, and ALM execution risk.
• The post-clean-up book has a short track record. The company's zero GNPA / NNPA statement applies to a company-defined restart AUM after clean-up and should be tested against FY2027 performance.

Capital Structure and Structural Points

• Avenir Investment RSC Limited, affiliated with International Holding Company PJSC, became promoter on March 31, 2026.
• Company materials state current IHC / Avenir ownership at 28.5% and ownership after warrant conversion at 43.5%; CRISIL separately cites 41.2% fully diluted ownership and potential ownership of 63.4% including an open offer.
• The initial capital received was Rs 5,652 crore, with Rs 3,198 crore of remaining warrant consideration expected.
• End-FY2026 equity was Rs 18,991 crore and company-disclosed gearing was 2.7x. Capital headroom requires confirmation through CRAR, Tier 1, Stage-wise loan data, and risk-weighted assets in the FY2026 annual report.
• Individual NCDs, retail bonds, subordinated debt, CP, and any foreign-currency bonds may differ materially in collateral, ranking, covenants, change-of-control terms, and guarantees.

Liquidity and Funding View

• End-FY2026 cash and cash equivalents, other bank balances, and investments were large and support near-term liquidity.
• Funding remains dependent on debt securities, other borrowings, subordinated liabilities, bank lines, securitisation / direct assignment, and market confidence.
• Domestic rating upgrades to AA+ / Stable from CRISIL, CARE, and ICRA support funding access, but the detailed CARE and ICRA rationales and rated debt lists remain to be checked.
• The board approved raising up to Rs 10,000 crore through debt securities in domestic and overseas markets. Actual tenor, collateral, currency, pricing, and use of proceeds are important confirmation items.

Credit Strengths

• Strong sponsor-support expectation after IHC / Avenir became promoter.
• Large capital injection and pending warrant consideration.
• Domestic AA+ / Stable rating recognition from multiple Indian rating agencies.
• Substantial end-FY2026 liquidity and investments.
• Potentially cleaner starting point after large FY2026 impairment and exceptional-loss recognition.
• Secured lending orientation, with housing finance as the largest product bucket.

Credit Weaknesses

• FY2026 full-year loss and Q4 FY2026 clean-up materially reduced equity.
• Limited post-restart operating track record.
• Commercial real estate and project-related lending remains a significant risk bucket.
• Market funding dependence is structurally higher than for banks with deposit franchises.
• Explicit sponsor guarantee, keepwell, ALM details, CRAR / Tier 1, unused committed lines, and detailed bond protections remain unconfirmed.

Rating Watchpoints

• Changes in IHC / Avenir ownership, warrant conversion, board control, or stated support stance.
• FY2027 return to profit, normalisation of credit costs, and absence of additional exceptional losses.
• GNPA, NNPA, Stage 2 / Stage 3 loans, ECL movement, write-offs, and recoveries after the restart.
• Execution terms for the Rs 10,000 crore debt-raising programme.
• CRISIL, CARE, ICRA, and any foreign-currency rating updates after the FY2026 annual report and Q1 FY2027 results.

Recurring Analytical Cautions

• Do not treat the company-defined restart AUM or zero GNPA / NNPA presentation as proof that future credit losses are eliminated.
• Do not equate IHC support expectations with a legal debt guarantee.
• Distinguish consolidated issuer credit from the legal terms and ranking of each bond.
• Interpret FY2026 losses as both evidence of legacy clean-up and a real capital reduction.
• Avoid comparing domestic AA+ ratings directly with global-scale ratings without adjusting for rating scale, sovereign, currency, and legal-structure risks.

Reliable Core Sources

• Sammaan Capital FY2026 earnings update dated May 20, 2026.
• Sammaan Capital March 31, 2026 IHC transaction press release.
• Sammaan Capital corporate announcements and financial-results pages.
• Sammaan Capital FY2025 annual report and Q3 FY2026 press release for background.
• CRISIL rating rationale dated April 9, 2026; CARE and ICRA public rating updates in May 2026.
• Internal structured metrics file: data/sammaan_capital_key_metrics_20260521.json.

Issuer Notes

This file is internal issuer coverage memory for research and writing judgment. It is not a change log. Detailed figures are stored in data/sammaan_capital_key_metrics_20260521.json; this file keeps monitoring items, unresolved questions, analytical cautions, and writing cautions.

Last updated: 2026-06-12

Ongoing Follow-Up Items

• Test the FY2027 quarterly results against the company's restart story: AUM growth, credit costs, delinquencies, collection performance, finance costs, and profitability.
• Monitor whether additional losses, ECL charges, recoveries, write-offs, collateral value changes, or asset-sale losses continue after the FY2026 legacy clean-up.
• Track whether the remaining Rs 3,198 crore warrant consideration is paid, how IHC / Avenir ownership changes, and whether the sponsor's management involvement deepens.
• Check liquidity through cash, bank balances, investments, committed / uncommitted lines, short-term debt, CP exposure, and ALM maturity buckets.
• Follow execution of the approved debt-raising programme of up to Rs 10,000 crore, including tenor, currency, fixed / floating rate, collateral, subordination, and use of proceeds.
• Watch domestic rating-agency follow-up after the FY2026 annual report and Q1 FY2027 results.

Unresolved Issues and Items to Check Next Time

• FY2026 annual report notes, especially exceptional loss components, ECL movement, Stage-wise loans, write-offs, collateral, tax effects, and differences between standalone and consolidated figures.
• CRAR, Tier 1, risk-weighted assets, regulatory constraints under RBI / NHB rules, and capital headroom after warrant conversion.
• Detailed ALM, maturity walls, unused committed facilities, CP ratio, liquid-investment quality, and foreign-currency hedging.
• Full CARE and ICRA rating rationales, rating sensitivities, and rated-debt lists.
• Individual bond documentation for NCDs, retail bonds, subordinated debt, CP, and any foreign-currency debt, including collateral cover, negative lien, cross default, change of control, put rights, coupon step-up, and guarantee language.
• Whether any IHC / Avenir guarantee, keepwell, letter of comfort, liquidity support agreement, or other legally enforceable sponsor support exists. Treat it as unconfirmed until the instrument documents prove it.

Analytical Cautions

• The issuer is a sponsor-supported reconstruction NBFC. Do not present it as a normalised high-quality NBFC until FY2027 earnings, asset quality, and funding performance confirm the restart.
• The FY2026 loss is not a simple recurring run rate, but it was still a real reduction in equity and capital flexibility.
• Commercial real estate and project-related exposure needs extra caution because it can be concentrated, collateral-dependent, and linked to past stress areas.
• Company-defined AUM, accounting loans, CRISIL-referenced AUM, and any securitised / assigned balances may use different scopes. Reconcile definitions before using trend language.
• Domestic AA+ ratings support Indian funding access but do not remove issuer-specific recovery, legal-structure, currency, and sponsor-support questions.

Report Wording Cautions

• Avoid wording that implies IHC guarantees Sammaan Capital debt unless a specific bond or support document confirms it.
• When referring to zero GNPA / NNPA, say it is the company's post-clean-up restart-AUM presentation, not proof that losses cannot arise.
• Avoid describing the Q4 FY2026 clean-up as purely positive; pair the potential reset benefit with the capital erosion.
• Separate company statements, rating-agency views, and Codex analytical conclusions.
• For any global or foreign-currency bond discussion, do not translate domestic AA+ ratings into global investment-grade language without explicit rating evidence.

Follow-Up on Management Strategy, Investment Plans, and Financial Policy

• Confirm whether growth targets for products and branches are accompanied by risk-management capacity, systems, staffing, and collections infrastructure.
• Monitor whether management prioritises profitable secured growth, asset-quality stabilisation, and funding diversification rather than rapid AUM expansion alone.
• Check whether the debt-raising programme lengthens maturities and diversifies funding or simply increases short-tenor market dependence.
• Track dividend policy, capital retention, and risk-asset growth once profitability resumes.

Items to Check for Ratings and Bond Investors

• CRISIL, CARE, ICRA, and any additional rating updates after FY2026 annual report and Q1 FY2027 results.
• Rating sensitivities around IHC ownership / support, GNPA, RoMA, funding access, and capitalisation.
• Rated-debt instrument lists and whether each rating maps to senior secured, senior unsecured, subordinated, CP, retail, or foreign-currency debt.
• Offering circulars, debenture trust deeds, term sheets, security cover certificates, and covenant compliance certificates for investable instruments.
• Market evidence for funding improvement, including actual issuance spreads, tenors, investor base, and any decline in funding costs.